Arcus Biosciences, Inc. (RCUS)
25.78
+0.71
(+2.83%)
USD |
NYSE |
Dec 10, 15:33
Arcus Biosciences Market Cap: 3.190B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Actinium Pharmaceuticals, Inc. | 45.23M |
| Apyx Medical Corp. | 155.64M |
| Gilead Sciences, Inc. | 150.15B |
| Merck & Co., Inc. | 242.34B |
| Karyopharm Therapeutics, Inc. | 111.00M |
Market Cap Related Metrics
| PS Ratio | 10.82 |
| PEG Ratio | -0.8556 |
| Price to Book Value | 7.316 |
| Price | 25.78 |
| Earnings Yield | -13.31% |
| PEGY Ratio | -0.8556 |